GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

Il Dong Pharmaceutical Co 249420.KS · KRW

Health Care · KRX · 🇰🇷 South Korea

Compare

12,250

0.00%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

5 analysts, 1 Feb 2026. The analysts' own views, not ours.

  • 2Strong buy
  • 2Buy
  • 1Hold
  • 0Sell
  • 0Strong sell

Price targets

Brokers' own targets, 1 Feb 2026. Not our view.

Average target 46,920

Low
46,460
Average
46,920
Median
46,920
High
48,300

Forecasts

Analyst averages for the fiscal years ahead

FY2026FY2027FY2028
Revenue₩597.50bn₩630.40bn₩669.70bn
Revenue, highest₩597.50bn₩630.40bn₩669.70bn
Revenue, lowest₩597.50bn₩630.40bn₩669.70bn
Earnings per share872.001181.001331.00
Earnings per share, highest872.001181.001331.00
Earnings per share, lowest872.001181.001331.00
Analysts111

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

1 / 10

Revenue growth 0.0% a year over 10 years. Return on equity 11.2%.

Model fair value

17,991.94

From earnings 17,991.94, from revenue 16,589.64.

Piotroski score

7 / 9

A nine-point test of financial strength, for 31 Dec 2025.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.